“We are grateful for the jury delivering what we believe is the largest Lanham Act jury trial award in U.S. history,” John C. Hueston of Hueston Hennigan LLP, who represents Monster.
Moez M. Kaba of Hueston Hennigan told Law360 the purpose of the lawsuit was to “reveal that Vital Pharmaceuticals has been engaged in an at least seven-year long campaign of deception, and we believe that the jury’s resounding verdict combined with the $185 million from our earlier case against Vital Pharmaceuticals — which totals about half a billion dollars in recovery — really sends that message once and for all. We’re very proud of that and our whole team is really proud of that work.”
Vital, Owoc and their counsel declined to comment.
The jury also ruled in Monster’s favor on several state law claims, finding that VPX stole trade secrets and interfered with Monster’s contracts over shelf space with some major retailers. The jury cleared Owoc of any liability on the contract claim, and he was not a defendant with respect to the trade secrets claim.
